Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling -- Mullen et al. 6 (1): 93 -- Molecular Cancer Therapeutics Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog